NSF Pharmalytica has added six scientists specializing in analytical testing, method development and validation to help companies achieve 510(k) compliance. The new team includes: Bethany DePaul, Scientist II, Matthew Johnson, MS, Scientist II, Kerry Medovich, Scientist III, Zemelia Miller, Scientist I, Amanda Pires, Scientist I, and Edie Wagner, Scientist I.
“Helping companies meet FDA compliance to 510(k) by testing for extractables and leachables in medical devices is part of our expertise. Each scientist helps to ensure clients receive effective, timely and cost-effective solutions to all of their testing needs including 510(k),” said Jim Scull, Ph.D., NSF Pharmalytica general manager.
NSF Pharmalytica is part of the Health Sciences Division of NSF International, a global independent public health organization that writes standards, and tests and certifies products for the health sciences, water, food, and consumer goods industries.